Glucose Health (GLUC) Gross Profit Margin starting from the third quarter 2017 to third quarter 2016, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Glucose Health, Inc.  (GLUC)


Glucose Health's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GLUC Gross Profit Margin (Sep 30 2017)
Q3 		(Jun 30 2017)
Q2 		(Mar 31 2017)
Q1 		(Dec 31 2016)
Q4 		(Sep 30 2016)
Q3
Y / Y Revenue Change 1027.16 %
Seq. Revenue Change -30.14 %
Revenue In Millions $0.02
Gross Profit Margin 96.68 %
Gross Profit Margin Total Ranking # 113
Gross Profit In Millions $0.02
Y / Y Gross Profit Change -
Seq. Gross Profit Change -31.92 %


Commenting Third Quarter 2017 Gross Profit Margin
Glucose Health, Inc. experienced contraction in Gross Profit by -31.92 % to $0 millions and Revenue by -30.14 %, while Gross Profit Margin fell to 96.68 %, above company*s average Gross Profit Margin.


Observing third quarter 2017 results within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 22 to 113.
Learn about Gross Margin
GLUC's Gross Profit Margin third quarter 2017 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 15
Overall # 101

Gross Profit Margin Statistics
High Average Low
99.2 % 47.23 % 3.13 %
(Jun 30 2017)   (Mar 31 2017)


GLUC Gross Income Trends • More of GLUC's Profitabilty Ratios • GLUC Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
GLUC's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
GLUC's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for GLUC's Competitors
Gross Profit Margin Profit Margin for Glucose Health's Suppliers
Gross Profit Margin Profit Margin for GLUC's Customers

You may also want to know
GLUC's Annual Growth Rates GLUC's Profitability Ratios GLUC's Asset Turnover Ratio GLUC's Dividend Growth
GLUC's Roe GLUC's Valuation Ratios GLUC's Financial Strength Ratios GLUC's Gross Profit Growth
GLUC's Roa GLUC's Inventory Turnover Ratio GLUC's Growth Rates GLUC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2017, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2017 MRQ Gross ProfitSep 30 2017 MRQ Revenue
Neurocrine Biosciences Inc   99.29 %$ 60.341  Millions$ 60.774  Millions
Sorrento Therapeutics Inc   99.11 %$ 120.825  Millions$ 121.910  Millions
Exelixis Inc   96.95 %$ 147.852  Millions$ 152.510  Millions
Lineage Cell Therapeutics Inc   96.92 %$ 1.636  Millions$ 1.688  Millions
Glucose Health, Inc.  96.68 %$ 0.023  Millions$ 0.024  Millions
Seagen Inc   93.33 %$ 126.272  Millions$ 135.291  Millions
Cyclo Therapeutics Inc   90.67 %$ 0.219  Millions$ 0.241  Millions
Biogen Inc   87.98 %$ 2,707.800  Millions$ 3,077.800  Millions
Biocryst Pharmaceuticals Inc   86.96 %$ 7.618  Millions$ 8.760  Millions
Halozyme Therapeutics Inc   86.93 %$ 55.399  Millions$ 63.731  Millions
Bluebird Bio Inc   85.73 %$ 6.611  Millions$ 7.711  Millions
Gilead Sciences Inc   84.15 %$ 5,480.000  Millions$ 6,512.000  Millions
Amgen Inc   82.85 %$ 4,783.000  Millions$ 5,773.000  Millions
Vivosim Labs Inc   81.25 %$ 1.101  Millions$ 1.355  Millions
Acorda Therapeutics Inc   78.74 %$ 111.073  Millions$ 141.065  Millions
Zeo Scientifix Inc   73.00 %$ 0.192  Millions$ 0.263  Millions
Nanostring Technologies Inc   72.96 %$ 19.711  Millions$ 27.016  Millions
Bio techne Corp  67.68 %$ 97.868  Millions$ 144.613  Millions
Enzo Biochem Inc  58.17 %$ 15.634  Millions$ 26.876  Millions
Xtant Medical Holdings Inc   57.47 %$ 11.373  Millions$ 19.789  Millions
Premier Biomedical Inc  54.40 %$ 0.013  Millions$ 0.024  Millions
Vericel Corporation  49.61 %$ 7.074  Millions$ 14.260  Millions
Champions Oncology Inc   49.01 %$ 2.550  Millions$ 5.203  Millions
Regenxbio Inc   48.88 %$ 0.653  Millions$ 1.336  Millions
Cellular Biomedicine Group Inc   48.22 %$ 0.051  Millions$ 0.107  Millions
Repligen Corp  45.36 %$ 16.593  Millions$ 36.580  Millions
Protalix Biotherapeutics inc   19.40 %$ 1.460  Millions$ 7.526  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.